[1] Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1):25-36.
[2] Guan HZ, Ren HT, Cui LY. Autoimmune encephalitis:an expanding frontier of neuroimmunology[J]. Chin Med J (Engl), 2016, 129(9):1122-1127.
[3] Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project[J]. Clin Infect Dis, 2012, 54(7):899-904.
[4] McKeon A. The importance of early and sustained treatment of a common autoimmune encephalitis[J]. Lancet Neurol, 2013, 12(2):123-125.
[5] Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:an observational cohort study[J]. Lancet Neurol, 2013, 12(2):157-165.
[6] Byrne S, McCoy B, Lynch B, et al. Does early treatment improve outcomes in N-methyl-D-aspartate receptor encephalitis?[J]. Dev Med Child Neurol, 2014, 56(8):794-796.
[7] Leypoldt F, Gelderblom M, Schöttle D, et al. Recovery from severe frontotemporal dysfunction at 3 years after N-methyl-d-aspartic acid (NMDA) receptor antibody encephalitis[J]. J Clin Neurosci, 2013, 20(4):611-613.
[8] 中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50(2):91-98.
[9] Zekeridou A, Karantoni E, Viaccoz A, et al. Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis[J]. J Neurol, 2015, 262(8):1859-1866.
[10] 张炜华, 王晓慧, 方方, 等. 抗N-甲基-D-天冬氨酸受体脑炎102例临床特征及随访[J]. 中国循证儿科杂志, 2016, 11(3):182-186.
[11] Nagappa M, Bindu PS, Mahadevan A, et al. Clinical features, therapeutic response, and follow-up in pediatric anti-N-methyl-D-aspartate receptor encephalitis:experience from a tertiary care university hospital in India[J]. Neuropediatrics, 2016, 47(1):24-32.
[12] 袁晶, 彭斌, 关鸿志, 等. 重症抗N-甲基-D-天冬氨酸受体脑炎35例免疫治疗分析[J]. 中华医学杂志, 2016, 96(13):1035-1039.
[13] Turkdoğan D, Orengul AC, Zaimoğlu S, et al. Anti-N-methyl-D-aspartate (Anti-NMDA) receptor encephalitis:rapid and sustained clinical improvement with steroid therapy starting in the late phase[J]. J Child Neurol, 2014, 29(5):684-687.
[14] Zivadinov R. Steroids and brain atrophy in multiple sclerosis[J]. J Neurol Sci, 2005, 233(1-2):73-81.
[15] Appenzeller S, Bonilha L, Rio PA, et al. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus[J]. Neuroimage, 2007, 34(2):694-701.
[16] Hung TY, Foo NH, Lai MC. Anti-N-methyl-D-aspartate receptor encephalitis[J]. Pediatr Neonatol, 2011, 52(6):361-364.
[17] Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis:the sixth special issue[J]. J Clin Apher, 2013, 28(3):145-284.
[18] DeSena AD, Noland DK, Matevosyan K, et al. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis:a retrospective review[J]. J Clin Apher, 2015, 30(4):212-216.
[19] 张桂菊, 刘小荣, 孟繁英, 等. 血浆置换在儿科的应用:附93例病例分析[J]. 中国小儿急救医学, 2015, 22(7):458-461.
[20] Kreye J, Wenke NK, Chayka M, et al. Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis[J]. Brain, 2016, 139(Pt 10):2641-2652.
[21] Dale RC, Pillai S, Brilot F. Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis[J]. Dev Med Child Neurol, 2013, 55(2):191-193.
[22] Harjunpää A, Wiklund T, Collan J, et al. Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma[J]. Leuk Lymphoma, 2001, 42(4):731-738.
[23] 卢强, 关鸿志, 任海涛, 等. 应用利妥昔单抗治疗抗N-甲基-D-天冬氨酸受体脑炎三例临床观察[J]. 中华神经科杂志, 2016, 49(1):30-34.
[24] Wong-Kisiel LC, Ji T, Renaud DL, et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis[J]. Neurology, 2010, 74(19):1550-1551.
[25] Dale RC, Brilot F, Duffy LV, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease[J]. Neurology, 2014, 83(2):142-150.
[26] Kavcic M, Fisher BT, Seif AE, et al. Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States[J]. J Pediatr, 2013, 162(6):1252-1258, 1258.e1.
[27] 赵力立, 罗蓉. 儿童抗N-甲基-D-天冬氨酸受体脑炎3例报告[J]. 中国实用儿科杂志, 2016, 31(4):315-317.
[28] Gabilondo I, Saiz A, Galán L, et al. Analysis of relapses in anti-NMDAR encephalitis[J]. Neurology, 2011, 77(10):996-999.
[29] 钟建民. 儿童抗N-甲基-D-天门冬氨酸受体脑炎的治疗[J]. 中国当代儿科杂志, 2014, 16(6):584-588.
[30] Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy:a meta-analysis[J]. J Womens Health (Larchmt), 2009, 18(3):311-319.
[31] Byrne S, Jordan I, Redmond J. Prevalence and treatment of anti-NMDA receptor encephalitis[J]. Lancet Neurol, 2013, 12(5):424.
[32] Bravo-Oro A, Abud-Mendoza C, Quezada-Corona A, et al. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis:experience with six pediatric patients. Potential efficacy of methotrexate[J]. Rev Neurol, 2013, 57(9):405-410.
[33] Tatencloux S, Chretien P, Rogemond V, et al. Intrathecal treatment of anti-N-Methyl-D-aspartate receptor encephalitis in children[J]. Dev Med Child Neurol, 2015, 57(1):95-99.
[34] Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies:clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens[J]. J Neurol Neurosurg Psychiatry, 2013, 84(7):748-755.
[35] Wang H. Efficacies of treatments for anti-NMDA receptor encephalitis[J]. Front Biosci (Landmark Ed), 2016, 21:651-663.
[36] 关鸿志, 崔丽英. 自身免疫性脑炎诊疗的规范化势在必行[J]. 中华神经科杂志, 2017, 50(2):81-82.
[37] Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis:a retrospective study[J]. Lancet Neurol, 2014, 13(2):167-177.
[38] Schein F, Gagneux-Brunon A, Antoine JC, et al. Anti-N-methyl-D-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis:an emerging disease with diagnosis and therapeutic challenges[J]. Infection, 2017, 45(4):545-549.